Related Experiment Video
Updated: Apr 8, 2026

Colonial Wig Pancreaticojejunostomy
Published on: March 12, 2019
Palliative parenteral nutrition use in patients with intestinal failure as a consequence of advanced pseudomyxoma
B R Disney1, A Karthikeyakurup1, J Ratcliffe1
1Department of Gastroenterology, Russells Hall Hospital, Dudley Group NHS Foundation Trust, Dudley, UK.
Abstract:
Pseudomyxoma peritonei (PMP) is a rare condition complicated by intra-abdominal spread that can cause multilevel gastrointestinal (GI) obstruction. Parenteral nutrition (PN) use in the context of palliative care and malignancy remains controversial. We describe the use of palliative PN in three patients with progressive PMP causing multilevel GI obstruction and intestinal failure. All patients received > 90 days of PN. PN was safe in this cohort of patients. However, patient selection and the timing of intervention are important factors when considering the initiation of PN.
Insights
Parenteral nutrition (PN) can be safely used in select patients with advanced pseudomyxoma peritonei (PMP) and intestinal failure. Careful patient selection and timing are crucial for successful palliative PN initiation.
Area of Science:
- Oncology
- Gastroenterology
- Palliative Care
Background:
- Pseudomyxoma peritonei (PMP) is a rare malignancy characterized by intra-abdominal spread.
- PMP can lead to multilevel gastrointestinal (GI) obstruction and intestinal failure.
- The role of parenteral nutrition (PN) in palliative care for advanced malignancy is debated.
Observation:
- This study describes the palliative use of PN in three patients with progressive PMP.
- All patients experienced multilevel GI obstruction and intestinal failure due to PMP.
- Patients received PN for over 90 days.
Findings:
- Palliative PN was found to be safe in this cohort of patients with PMP.
- No major complications directly related to PN were reported.
- The study highlights the feasibility of long-term PN in this challenging patient group.
Implications:
- PN can be a viable option for managing intestinal failure in advanced PMP.
- Judicious patient selection and appropriate timing of PN initiation are critical for optimal outcomes.
- Further research is warranted to establish clear guidelines for PN use in palliative oncology.
Related Concept Videos
Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube...
Parentral Nutrition: Centeral and Peripheral Parental Nutrition
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Enteral Nutrition I: Orogastric and Nasogastric Feeding
Orogastric (OG) and nasogastric (NG) feeding are two standard methods used for enteral nutrition. Enteral nutrition is often preferred over...
Peritoneal Dialysis III: Nursing Management

